comparemela.com

Latest Breaking News On - Joseph mannello - Page 1 : comparemela.com

MYOS CORP Announces Publication of Peer Reviewed Study on the Impact of Fortetropin® in Geriatric and Arthritic Dogs

MYOS CORP Announces Completion of Human Clinical Trial on the Impact of Fortetropin During Muscle Disuse in Healthy, Young Men

MYOS CORP Announces Peer Reviewed Study on The Impact of Fortetropin in Arthritic Dogs Has Been Accepted for Publication

MYOS CORP Announces Formation of Veterinary Advisory Board

Press release content from PR Newswire. The AP news staff was not involved in its creation. MYOS CORP Announces Formation of Veterinary Advisory Board February 2, 2021 GMT (PRNewsfoto/MYOS RENS Technology) CEDAR KNOLLS, N.J., Feb. 2, 2021 /PRNewswire/ MYOS CORP (“MYOS” or the “Company”), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced today that it has formed a Veterinary Advisory Board (“VAB”) for its Animal Health Business. The VAB is comprised of leading experts in areas such as Small Animal Rehabilitation and Sports Medicine, Veterinary Nutrition, Chronic Kidney Disease, Canine Osteoarthritis and Pain Management. Its members consist of veterinarians in private practice and professors at leading veterinary colleges. The VAB will advise MYOS on new product development, future clinical studies, and communication strategies within the veterinarian industry.

MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand

MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand News provided by Share this article CEDAR KNOLLS, N.J., Dec. 21, 2020 /PRNewswire/  MYOS CORP ( MYOS or the Company ), a research-based advanced nutrition company with divisions that address both Human Nutrition and Science Biotech to exclusively distribute its  Fortetropin ® products in Australia and New Zealand. Fortetropin is a proprietary advanced nutrition product developed and owned by MYOS that has been shown in multiple human and veterinary clinical studies to accelerate gains in muscle mass, improve mobility, and enhance recovery from injury. We are very pleased to announce our partnership with Science Biotech. In Science Biotech we found a partner that is incredibly passionate about our products. Due to its sporting culture and love of pets, Australia was identified as a key market for us, and we couldn t be happier with the fit we

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.